Focal Therapy Options for Prostate Cancer

Ablative Therapy in the Management of Prostate Cancer

Recruiting Observational Study
Prostate Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Male
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Weill Medical College of Cornell University · Other
Who this trial is looking for

This trial is looking for men who are either starting or have had a type of treatment for prostate cancer called focal therapy. Participants will help gather information about how these treatments are working.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am over 18 years old.
  • I am undergoing focal therapy for prostate cancer.
  • I have received prior focal therapy for prostate cancer.

You may not be able to join if

  • I have cancer that has spread to other parts of my body.
  • I am unable to complete a questionnaire in English.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The purpose of this study is collect observational data regarding patterns of care and outcomes of focal therapies for prostate cancer, including but not limited to: high-intensity focused ultrasound (HIFU), cryotherapy, focal laser ablation, irreversible electroporation, photodynamic therapy, and brachytherapy.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * \>18 years of age * Undergoing focal therapy for primary or salvage treatment of prostate cancer, or * Have received prior focal therapy Exclusion Criteria: * Clinically-evident metastatic disease * Unable to fill out an English-language questionnaire
Contacts

Holly Kuczynsk, BS

646-962-7523

hok4001@med.cornell.edu

CONTACT